Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP971305.RAMgfjIDfvYNKeC9PLd-35e9goFkWNmL6URoX2lR5fFGk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP971305.RAMgfjIDfvYNKeC9PLd-35e9goFkWNmL6URoX2lR5fFGk130_assertion type Assertion NP971305.RAMgfjIDfvYNKeC9PLd-35e9goFkWNmL6URoX2lR5fFGk130_head.
- NP971305.RAMgfjIDfvYNKeC9PLd-35e9goFkWNmL6URoX2lR5fFGk130_assertion description "[We found that (1) a myristoylated HBVpreS/2-48-GST fusion protein efficiently interferes with HBV infection of HepaRG cells; (2) deletions and point mutations in the highly conserved preS1 sequence between amino acids 11 through 21 result in the loss of infection inhibition activity; (3) hepatitis B viruses carrying single amino acid exchanges within this region lose infectivity; and (4) HDV infection of HepaRG cells can be inhibited by myristoylated HBVpreS peptides with the same specificity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP971305.RAMgfjIDfvYNKeC9PLd-35e9goFkWNmL6URoX2lR5fFGk130_provenance.
- NP971305.RAMgfjIDfvYNKeC9PLd-35e9goFkWNmL6URoX2lR5fFGk130_assertion evidence source_evidence_literature NP971305.RAMgfjIDfvYNKeC9PLd-35e9goFkWNmL6URoX2lR5fFGk130_provenance.
- NP971305.RAMgfjIDfvYNKeC9PLd-35e9goFkWNmL6URoX2lR5fFGk130_assertion SIO_000772 16557545 NP971305.RAMgfjIDfvYNKeC9PLd-35e9goFkWNmL6URoX2lR5fFGk130_provenance.
- NP971305.RAMgfjIDfvYNKeC9PLd-35e9goFkWNmL6URoX2lR5fFGk130_assertion wasDerivedFrom befree-20150227 NP971305.RAMgfjIDfvYNKeC9PLd-35e9goFkWNmL6URoX2lR5fFGk130_provenance.
- NP971305.RAMgfjIDfvYNKeC9PLd-35e9goFkWNmL6URoX2lR5fFGk130_assertion wasGeneratedBy ECO_0000203 NP971305.RAMgfjIDfvYNKeC9PLd-35e9goFkWNmL6URoX2lR5fFGk130_provenance.